 |
|
|
| |
Real World Effectiveness of 8 and 12 Weeks of Ledipasvir/Sofosbuvir (LDV/SOF) in Blacks with HCV:
A Comparative Analysis of Clinical Trials with Real World Cohorts
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting®, October 20-24, 2017, Washington, DC
E Wilson1, S Kattakuzhy2, P Kwo3, P Davitkov4, K Qureshi5, V Sundaram6, S Naik7, L Williams7, J Wolf7, J Llewellyn7, A Osinusi7, DM Brainard7, S Gordon8, L Backus9, KV Kowdley10
1Veterans Affairs, Baltimore, MD; 2Institute of Human Virology at the University of Maryland, Baltimore, MD; 3Stanford University Medical Center, Stanford, CA; 4Veterans Affairs, Cleveland, OH; 5Temple University, Philadelphia, PA, USA;
6University Of California at Los Angeles, Los Angeles, CA; 7Gilead Sciences, Foster City, CA, USA; 8Henry Ford Health System , Detroit, MI; 9Veterans Affairs Palo Alto Health Care System, Palo Alto, CA; 10Swedish Medical Center, Seattle, WA.
|
| |
|
|
|
|
|
